Holen Sie sich die Stockscreener-App
15.87
1.80%
0.28
Handel nachbörslich:
15.95
0.08
+0.50%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.59
Offen:
$15.47
24-Stunden-Volumen:
413.94K
Relative Volume:
0.32
Marktkapitalisierung:
$730.22M
Einnahmen:
$203.27M
Nettoeinkommen (Verlust:
$-4.66M
KGV:
-158.70
EPS:
-0.1
Netto-Cashflow:
$3.47M
1W Leistung:
-6.09%
1M Leistung:
-3.29%
6M Leistung:
-1.18%
1J Leistung:
+11.37%
1-Tages-Spanne:
$15.27
$16.07
1-Wochen-Bereich:
$15.27
$17.31
52-Wochen-Spanne:
$9.215
$21.00
Axogen Inc Stock (AXGN) Company Profile
Firmenname
Axogen Inc
Sektor
Branche
Telefon
(386) 462-6817
Adresse
13631 PROGRESS BLVD., ALACHUA, FL
Vergleichen Sie AXGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AXGN
Axogen Inc
|
15.87 | 717.34M | 203.27M | -4.66M | 3.47M | -0.10 |
|
ABT
Abbott Laboratories
|
133.27 | 228.66B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
96.24 | 140.69B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
370.00 | 139.51B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
96.54 | 122.60B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.36 | 42.83B | 5.69B | 1.41B | 577.90M | 6.9828 |
Axogen Inc Stock (AXGN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-17 | Eingeleitet | Lake Street | Buy |
| 2024-07-01 | Eingeleitet | Raymond James | Outperform |
| 2022-11-11 | Fortgesetzt | Jefferies | Buy |
| 2022-05-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2022-03-11 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-10-23 | Eingeleitet | Guggenheim | Buy |
| 2020-06-16 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2020-05-07 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2020-04-02 | Herabstufung | BTIG Research | Buy → Neutral |
| 2019-08-07 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2019-07-12 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-03-02 | Bestätigt | Lake Street | Buy |
| 2018-01-05 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-11-30 | Eingeleitet | Jefferies | Buy |
| 2017-11-21 | Bestätigt | Lake Street | Buy |
| 2017-07-31 | Eingeleitet | Leerink Partners | Outperform |
| 2017-06-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2017-03-06 | Eingeleitet | ROTH Capital | Buy |
| 2016-11-22 | Hochstufung | Lake Street | Hold → Buy |
| 2016-11-07 | Bestätigt | Wedbush | Outperform |
| 2016-11-03 | Herabstufung | Lake Street | Buy → Hold |
| 2016-08-04 | Bestätigt | Wedbush | Outperform |
| 2014-05-14 | Eingeleitet | Dawson James | Buy |
| 2013-10-31 | Bestätigt | Ladenburg Thalmann | Buy |
Alle ansehen
Axogen Inc Aktie (AXGN) Neueste Nachrichten
Axogen Inc. recovery potential after sell offEarnings Trend Report & Breakout Confirmation Alerts - newser.com
What’s next for Axogen Inc. stock price2025 Big Picture & Reliable Intraday Trade Plans - newser.com
Order flow analysis tools used on Axogen Inc.Weekly Trade Review & Verified Short-Term Plans - newser.com
Axogen gains on report of takeover interest - MSN
Price action breakdown for Axogen Inc.Dip Buying & Long-Term Safe Investment Ideas - newser.com
Volume spikes in Axogen Inc. stock – what they meanWeekly Investment Report & Fast Gain Stock Tips - newser.com
Axogen Inc. stock trend outlook and recovery path2025 Major Catalysts & Capital Protection Trading Alerts - newser.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Axogen, Inc. (AXGN) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Visual analytics tools that track Axogen Inc. performanceJuly 2025 Catalysts & Weekly Setup with ROI Potential - newser.com
Will Axogen Inc. stock deliver strong dividend growthJuly 2025 News Drivers & Reliable Breakout Stock Forecasts - newser.com
Real time social sentiment graph for Axogen Inc.Trade Analysis Report & Reliable Entry Point Trade Alerts - newser.com
Can Axogen Inc. stock continue upward trendMarket Sentiment Review & Weekly Consistent Profit Watchlists - newser.com
Predicting Axogen Inc. trend using moving averagesJuly 2025 PostEarnings & Weekly Hot Stock Watchlists - newser.com
Will Axogen Inc. stock gain from government policies2025 Analyst Calls & Weekly High Momentum Picks - newser.com
How risky is Axogen Inc. stock nowAnalyst Upgrade & Stock Market Timing Techniques - newser.com
Axogen, Inc. (AXGN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
AxoGen (NASDAQ:AXGN) Stock Price Passes Above 200-Day Moving AverageHere's What Happened - MarketBeat
Why Axogen Inc. is moving today2025 Market Outlook & Reliable Breakout Forecasts - newser.com
How sentiment analysis helps forecast Axogen Inc.Portfolio Update Report & Verified Momentum Watchlists - newser.com
Can Axogen Inc. stock weather global recessionJuly 2025 Decliners & Low Risk High Reward Ideas - newser.com
AxoGen's (AXGN) "Sell (D-)" Rating Reaffirmed at Weiss Ratings - MarketBeat
Market reaction to Axogen Inc.’s recent newsQuarterly Growth Report & Detailed Earnings Play Alerts - newser.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc.AXGN - WV News
Axogen, Inc. Experiences Evaluation Revision Amidst Shifting Market Dynamics and Performance Indicators - Markets Mojo
Insider Sell: Burke William P. Mr. Sells Shares of Axogen Inc (A - GuruFocus
William Mr. Burke Sells 736 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
Axogen Stock Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
William Mr. Burke Sells 14,571 Shares of AxoGen (NASDAQ:AXGN) Stock - MarketBeat
AxoGen (NASDAQ:AXGN) Director Sells $137,236.20 in Stock - MarketBeat
Axogen Director William P. Burke Sells Over 32,000 Shares - TradingView
Bronstein, Gewirtz & Grossman, LLC Encourages Axogen, Inc. (AXGN) Investors to Inquire about Securities Investigation - ACCESS Newswire
How to recover losses in Axogen Inc. stockJuly 2025 Earnings & Reliable Momentum Entry Alerts - newser.com
Is FDA Review Delay and Legal Scrutiny Altering the Investment Case for Axogen (AXGN)? - Sahm
A Look at Axogen (AXGN) Valuation Following FDA Avance Delay and Securities Law Probe - Yahoo Finance
AxoGen, Inc. (NASDAQ:AXGN) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Axogen, Inc. (AXGN) And Encourages Stockholders to Reach Out - ACCESS Newswire
Combining price and volume data for Axogen Inc.Trend Reversal & Safe Investment Capital Preservation Plans - newser.com
Finanzdaten der Axogen Inc-Aktie (AXGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.19%
1.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):